Effect of systemic inflammation on inspiratory and limb muscle strength and bulk in cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 180, Issue 2, 2009, Pages 153-158

  Dufresne, Valérie ^a   Knoop, Christiane ^a   Van Muylem, Alain ^a   Malfroot, Anne ^b   Lamotte, Michel ^a   Opdekamp, Christian ^a   Deboeck, Gaël ^a   Cassart, Marie ^a   Stallenberg, Bernard ^a   Casimir, Georges ^c   Duchateau, Jean ^d   Estenne, Marc ^a  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^d BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Acute phase reaction; Airway obstruction; Lung infection; Skeletal muscles

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; CYTOKINE;

ADULT; AIRWAY RESISTANCE; ARTICLE; BICEPS BRACHII MUSCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; LEUKOCYTE; LEUKOCYTOSIS; LUNG FIBROSIS; MALE; MUSCLE STRENGTH; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; ARM; BLOOD; BODY MASS; CASE CONTROL STUDY; CYSTIC FIBROSIS; DIAPHRAGM; INFLAMMATION; LEG; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

ADULT; AIRWAY RESISTANCE; ARM; BODY MASS INDEX; CASE-CONTROL STUDIES; CYSTIC FIBROSIS; CYTOKINES; DIAPHRAGM; FEMALE; HUMANS; INFLAMMATION; LEG; MALE; MUSCLE STRENGTH; MUSCLE, SKELETAL; YOUNG ADULT;

EID: 67650733855     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200802-232OC     Document Type: Article

References (36)

1. Mitch WE, Goldberg AL. Mechanisms of muscle wasting: the role of the ubiquitin-proteasome pathway. N Engl J Med 1996;335:1897-1905.
2. Späte U, Schulze PC. Proinflammatory cytokines and skeletal muscle. Curr Opin Clin Nutr Metab Care 2004;7:265-269.
3. Langen RC, Schols AM, Kelders MC, van der Velden JL, Wouters EF, Janssen-Heininger YM. Muscle wasting and impaired muscle regeneration in a murine model of chronic pulmonary inflammation. Am J Respir Cell Mol Biol 2006;35:689-696.
4. Divangahi M, Matecki S, Dudley RW, Tuck SA, Bao W, Radzioch D, Comtois AS, Petrof BJ. Preferential diaphragmatic weakness during sustained Pseudomonas aeruginosa lung infection. Am J Respir Crit Care Med 2004;169:679-686. (Pubitemid 38338919)
5. van Heeckeren AM, Tscheikuna J, Walenga RW, Konstan MW, Davis PB, Erokwu B, Haxhiu MA, Ferkol TW. Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice. Am J Respir Crit Care Med 2000;161:271-279. (Pubitemid 30055936)
6. Tsujinaka T, Fujita J, Ebisui C, Yano M, Kominami E, Suzuki K, Tanaka K, Katsume A, Ohsugi Y, Shiozaki H, et al. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest 1996;97: 244-249. (Pubitemid 26022595)
7. Haddad F, Zaldivar F, Cooper DM, Adams GR. IL-6-induced skeletal muscle atrophy. J Appl Physiol 2005;98:911-917.
8. Langen RC, Schols AM, Kelders MC, Wouters EF, Janssen-Heininger YM. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. FASEB J 2001;15: 1169-1180.
9. Yende S,Waterer GW, Tolley EA, Newman AB, Bauer DC, Taaffe DR, Jensen R, Crapo R, Rubin S, Nevitt M, et al. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax 2006;61:10-16. (Pubitemid 43106971)
10. Pinet C, Cassart M, Scillia P, Lamotte M, Knoop C, Casimir G, Mélot C, Estenne M. Function and bulk of respiratory and limb muscles in patients with CF. Am J Respir Crit Care Med 2003;168:989-994. (Pubitemid 37267178)
11. Dufresne V, Knoop C, Malfroot A, Lamotte M, Opdekamp C, Deboeck G, Cassart M, Stallenberg B, Vandenbroeck J, Casimir G, et al. Effect of inflammation on strength and bulk of respiratory and limb muscles in CF (CF). Am J Respir Crit Care Med 2007;175:A952.
12. Faul F, Erdfelder E, Lang AG, Buchner AG. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175-191.
13. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136.
14. American Thoracic Society/European Respiratory Society. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 2002;166:518-624.
15. Vuillemin A, Oppert JM, Guillemin F, Essermeant L, Fontvieille AM, Galan P, Kriska AM, Hercberg S. Self-administered questionnaire compared with interview to assess past-year physical activity. Med Sci Sports Exerc 2000;32:1119-1124. (Pubitemid 30390276)
16. Sin DD, Lacy P, York E, Man SF. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:760-765. (Pubitemid 39298991)
17. Moser C, Tirakitsoontorn P, Nussbaum E, Newcomb R, Cooper DM. Muscle size and cardiorespiratory response to exercise in CF. Am J Respir Crit Care Med 2000;162:1823-1827. (Pubitemid 30947567)
18. Rosenthal M, Narang I, Edwards L, Bush A. Non-invasive assessment of exercise performance in children with cystic fibrosis (CF) and noncystic fibrosis bronchiectasis: is there a CF specific muscle defect? Pediatr Pulmonol 2009;44:222-230.
19. Gauthier AP, Verbanck S, Estenne M, Segebarth C, Macklem PT, Paiva M. Three-dimensional reconstruction of the in vivo human diaphragm shape at different lung volumes. Am J Respir Crit Care Med 1994;76: 495-506.
20. Bellemare F, Jeanneret A. Sex differences in thoracic adaptation to pulmonary hyperinflation in CF. Eur Respir J 2007;29:98-107. (Pubitemid 46092004)
21. Sagel ND. Noninvasive biomarkers of airway inflammation in CF. Curr Opin Pulm Med 2003;9:516-521.
22. McAllister F, Henry A, Kreindler JL, Dubin PJ, Ulrich L, Steele C, Finder JD, Pilewski JM, Carreno BM, Goldman SJ, et al. Role of IL- 17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in CF. J Immunol 2005;175:404-412. (Pubitemid 40884344)
23. Nixon LS, Yung B, Bell SC, Elborn JS, Shale DJ. Circulating immunoreactive interleukin-6 in CF. Am J Respir Crit Care Med 1998;157: 1764-1769.
24. Ionescu AA, Nixon LS, Evans WD, Stone MD, Lewis-Jenkins V, Chatham K, Shale DJ. Bone density, body composition, and inflammatory status in CF. Am J Respir Crit Care Med 2000;162:789-794.
25. Ionescu AA, Nixon LS, Luzio S, Lewis-Jenkins V, Evans WD, Stone MD, Owens DR, Routledge PA, Shale DJ. Pulmonary function, body composition, and protein catabolism in adults with CF. Am J Respir Crit Care Med 2002;165:495-500. (Pubitemid 34165473)
26. Ionescu AA, Evans WD, Pettit RJ, Nixon LS, Stone MD, Shale DJ. Hidden depletion of fat-free mass and bone mineral density in adults with CF. Chest 2003;124:2220-2228. (Pubitemid 38010593)
27. Schmitt-Grohé S, Naujoks C, Bargon J, Wagner TO, Schubert R, Hippe V, Zielen S. Interleukin-8 in whole blood and clinical status in CF. Cytokine 2005;29:18-23. (Pubitemid 39576699)
28. Mayer-Hamblett N, Aitken ML, Accurso FJ, Kronmal RA, Konstan MW, Burns JL, Sagel SD, Ramsey BW. Association between pulmonary function and sputum biomarkers in CF. Am J Respir Crit Care Med 2007;175:822-828. (Pubitemid 46631794)
29. Supinski GS, Callahan LA. Free radical-mediated skeletal muscle dysfunction in inflammatory conditions. J Appl Physiol 2007;102: 2056-2063.
30. Debigaré R, Côté CH, Maltais F. Peripheral muscle wasting in chronic obstructive pulmonary disease: clinical relevance and mechanisms. Am J Respir Crit Care Med 2001;164:1712-1717. (Pubitemid 33124163)
31. Jagoe RT, Engelen MP. Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease. Eur Respir J Suppl 2003;46:52s-63s.
32. Barreiro E, Schols AM, Polkey MI, Galdiz JB, Gosker HR, Swallow EB, Coronell C, Gea J. ENIGMA in COPD project. Cytokine profile in quadriceps of patients with severe COPD. Thorax 2008;63:100-107.
33. Langen RC, Schols AM. Inflammation: friend or foe of muscle remodelling in COPD? Eur Respir J 2007;30:605-607.
34. Sin DD, Reid WD. Is inflammation good, bad, or irrelevant for skeletal muscles in COPD? Thorax 2008;63:95-96.
35. Sin DD, Man SFP. Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link? Thorax 2006;61:1-3.
36. Remels AH, Gosker HR, van der Velden J, Langen RC, Schols AM. Systemic inflammation and skeletal muscle dysfunction in chronic obstructive pulmonary disease: state of the art and novel insights in regulation of muscle plasticity. Clin Chest Med 2007;28:537-552. (Pubitemid 47284588)